News

Title: 12th International Congress on Pulmonary Diseases, Intensive Care and Tuberculosis

The 12th International Congress on Pulmonary Diseases, Intensive Care and Tuberculosis will be held on October 6–9, 2026, at the Shahid Beheshti University Conference Center (Aboureihan), Tehran. Organized by Dr. Masih Daneshvari Hospital, Research, Educational and Medical Center for Tuberculosis and Lung Diseases, the congress is supported by numerous national and international scientific societies, including

Title: 12th International Congress on Pulmonary Diseases, Intensive Care and Tuberculosis Read More »

New International Patent Granted: Esophageal Echocardiography Device with Fluid Control and Image Clarification

We are proud to announce that Dr. Azin Alizadehasl, together with co-inventors Masoud Arabamery and Mohammadhossein Sharifnia, has been granted international patent protection (WO/2026/181056) for a novel mobile esophageal echocardiography device. This invention, which previously received the Gold Award at the 6th International Invention and Innovation Competition (IFIA, Geneva), has now also secured international patent

New International Patent Granted: Esophageal Echocardiography Device with Fluid Control and Image Clarification Read More »

Dr. Azin Alizadehasl Wins Gold Award at IFIA Geneva

Dr. Azin Alizadehasl Wins Gold Award at IFIA Geneva

Dr. Azin Alizadehasl, Professor at Rajaie Cardiovascular Medical and Research Institute, has been awarded the Gold Award at the 6th International Exhibition of Inventions of Geneva (IFIA), for her invention: “A Device and Method for Image Clarification in Transesophageal Echocardiography.” The Institute’s Vice President for Research congratulated her on this significant scientific and innovative achievement.

Dr. Azin Alizadehasl Wins Gold Award at IFIA Geneva Read More »

Machine learning based radiomics model to predict radiotherapy induced cardiotoxicity in breast cancer

Abstract Purpose: Cardiotoxicity is one of the major concerns in breast cancer treatment, significantly affecting patient outcomes. To improve the likelihood of favorable outcomes for breast cancer survivors, it is essential to carefully balance the potential advantages of treatment methods with the risks of harm to healthy tissues, including the heart. There is currently a lack

Machine learning based radiomics model to predict radiotherapy induced cardiotoxicity in breast cancer Read More »